Show simple item record

dc.contributor.authorAhmad, Nabeelen_US
dc.contributor.authorWelch, Ianen_US
dc.contributor.authorGrange, Roberten_US
dc.contributor.authorHadway, Jenniferen_US
dc.contributor.authorDhanvantari, Savitaen_US
dc.contributor.authorHill, Daviden_US
dc.contributor.authorLee, Ting-Yimen_US
dc.contributor.authorHoffman, Lisa Men_US
dc.date.accessioned2012-08-24T11:04:14Z
dc.date.available2012-08-24T11:04:14Z
dc.date.issued2011-06-04
dc.identifier.citationBMC Musculoskeletal Disorders. 2011 Jun 04;12(1):127en_US
dc.identifier.urihttp://hdl.handle.net/10919/18803
dc.description.abstractBackground Duchenne muscular dystrophy (DMD) is a severe neuromuscular disease that affects 1 in 3500 boys. The disease is characterized by progressive muscle degeneration that results from mutations in or loss of the cytoskeletal protein, dystrophin, from the glycoprotein membrane complex, thus increasing the susceptibility of contractile muscle to injury. To date, disease progression is typically assessed using invasive techniques such as muscle biopsies, and while there are recent reports of the use of magnetic resonance, ultrasound and optical imaging technologies to address the issue of disease progression and monitoring therapeutic intervention in dystrophic mice, our study aims to validate the use of imaging biomarkers (muscle perfusion and metabolism) in a longitudinal assessment of skeletal muscle degeneration/regeneration in two murine models of muscular dystrophy. Methods Wild-type (w.t.) and dystrophic mice (weakly-affected mdx mice that are characterized by a point mutation in dystrophin; severely-affected mdx:utrn-/- (udx) mice that lack functional dystrophin and are null for utrophin) were exercised three times a week for 30 minutes. To follow the progression of DMD, accumulation of 18 F-FDG, a measure of glucose metabolism, in both wild-type and affected mice was measured with a small animal PET scanner (GE eXplore Vista). To assess changes in blood flow and blood volume in the hind limb skeletal muscle, mice were injected intravenously with a CT contrast agent, and imaged with a small animal CT scanner (GE eXplore Ultra). Results In hind limb skeletal muscle of both weakly-affected mdx mice and in severely-affected udx mice, we demonstrate an early, transient increase in both 18F-FDG uptake, and in blood flow and blood volume. Histological analysis of H&E-stained tissue collected from parallel littermates demonstrates the presence of both inflammatory infiltrate and centrally-located nuclei, a classic hallmark of myofibrillar regeneration. In both groups of affected mice, the early transient response was succeeded by a progressive decline in muscle perfusion and metabolism; this was also evidenced histologically. Conclusions The present study demonstrates the utility of non-invasive imaging biomarkers in characterizing muscle degeneration/regeneration in murine models of DMD. These techniques may now provide a promising alternative for assessing both disease progression and the efficacy of new therapeutic treatments in patients.en_US
dc.format.mimetypeapplication/pdf
dc.language.isoen_US
dc.rightsCreative Commons Attribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleUse of Imaging Biomarkers to Assess Perfusion and Glucose Metabolism in the Skeletal Muscle of Dystrophic Miceen_US
dc.typeArticle - Refereed
dc.date.updated2012-08-24T11:04:14Z
dc.description.versionPeer Reviewed
dc.rights.holderNabeel Ahmad et al.; licensee BioMed Central Ltd.en_US
dc.contributor.departmentHuman Nutrition, Foods, and Exerciseen_US
dc.contributor.departmentSchool of Biomedical Engineering and Sciencesen_US
dc.title.serialBMC Musculoskeletal Disorders
dc.identifier.doihttps://doi.org/10.1186/1471-2474-12-127
dc.type.dcmitypeText


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution 4.0 International
License: Creative Commons Attribution 4.0 International